Trial intelligence / Profile preview

Acupuncture versus beconase for allergic rhinitis

2006-000947-24Phase 4Unknown

Sponsor
Peterborough and Stamford Hospitals NHS Foundation Trust
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of beclomethasone dipropionate in allergic rhinitis (AR) (2 arms), sponsored by Peterborough and Stamford Hospitals NHS Foundation Trust. Primary endpoint: recurrence of allergic rhinitis. Status: unknown.

02

Drugs

beclomethasone dipropionate
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on 2006-000947-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000947-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call